Combined with the above observations in our manuscript, we speculate that, on the one hand, high levels of PRMT5 may serve as a biomarker for Taxol resistance in ovarian cancer, and, on the other hand, high expression of PRMT5 may be an important mechanism of cancer cell resistance to Taxol. The gene discussed is PRMT5; the disease is ovarian cancer.